Skip to content 
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. It has a strategic collaboration with Sarah Cannon Research Institute to enhance clinical trial processes. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is based in Durham, North Carolina. more
| Time Frame | IQV | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | -10.96% | -1.08% | -1.38% |
| 1-Month Return | -30.89% | -0.47% | -1.81% |
| 3-Month Return | -25.32% | 2.13% | 1.38% |
| 6-Month Return | -12.24% | 17.04% | 5.68% |
| 1-Year Return | -14.85% | 6.56% | 11.74% |
| 3-Year Return | -28.08% | 16.78% | 65.15% |
| 5-Year Return | -12.37% | 34.34% | 73.68% |
| 10-Year Return | 170.17% | 137.88% | 260.03% |
| Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | 5YR TREND | |
|---|---|---|---|---|---|---|
| Total Revenue | 13.87B | 14.41B | 14.98B | 15.40B | 16.31B | [{"date":"2021-12-31","value":85.06,"profit":true},{"date":"2022-12-31","value":88.35,"profit":true},{"date":"2023-12-31","value":91.87,"profit":true},{"date":"2024-12-31","value":94.45,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Cost of Revenue | 9.23B | 9.38B | 9.74B | 10.03B | 12.02B | [{"date":"2021-12-31","value":76.79,"profit":true},{"date":"2022-12-31","value":78.03,"profit":true},{"date":"2023-12-31","value":81.05,"profit":true},{"date":"2024-12-31","value":83.42,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Gross Profit | 4.64B | 5.03B | 5.24B | 5.38B | 4.29B | [{"date":"2021-12-31","value":86.34,"profit":true},{"date":"2022-12-31","value":93.54,"profit":true},{"date":"2023-12-31","value":97.47,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":79.74,"profit":true}] |
| Gross Margin | 33.45% | 34.89% | 34.96% | 34.89% | 26.28% | [{"date":"2021-12-31","value":95.67,"profit":true},{"date":"2022-12-31","value":99.8,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":99.79,"profit":true},{"date":"2025-12-31","value":75.16,"profit":true}] |
| Operating Expenses | 3.25B | 3.23B | 3.26B | 3.17B | 2.00B | [{"date":"2021-12-31","value":99.57,"profit":true},{"date":"2022-12-31","value":98.99,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":97.27,"profit":true},{"date":"2025-12-31","value":61.28,"profit":true}] |
| Operating Income | 1.39B | 1.80B | 1.98B | 2.20B | 2.29B | [{"date":"2021-12-31","value":60.91,"profit":true},{"date":"2022-12-31","value":78.66,"profit":true},{"date":"2023-12-31","value":86.45,"profit":true},{"date":"2024-12-31","value":96.28,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Total Non-Operating Income/Expense | (628.00M) | (851.00M) | (1.15B) | (1.16B) | - | [{"date":"2021-12-31","value":-62800000000,"profit":false},{"date":"2022-12-31","value":-85100000000,"profit":false},{"date":"2023-12-31","value":-115400000000,"profit":false},{"date":"2024-12-31","value":-115600000000,"profit":false},{"date":"2025-12-31","value":"-","profit":true}] |
| Pre-Tax Income | 1.13B | 1.35B | 1.46B | 1.67B | 1.61B | [{"date":"2021-12-31","value":67.94,"profit":true},{"date":"2022-12-31","value":80.95,"profit":true},{"date":"2023-12-31","value":87.42,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":96.64,"profit":true}] |
| Income Taxes | 163.00M | 260.00M | 101.00M | 296.00M | 252.00M | [{"date":"2021-12-31","value":55.07,"profit":true},{"date":"2022-12-31","value":87.84,"profit":true},{"date":"2023-12-31","value":34.12,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":85.14,"profit":true}] |
| Income After Taxes | 971.00M | 1.09B | 1.36B | 1.37B | - | [{"date":"2021-12-31","value":70.72,"profit":true},{"date":"2022-12-31","value":79.46,"profit":true},{"date":"2023-12-31","value":98.91,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Income From Continuous Operations | 971.00M | 1.09B | 1.36B | 1.37B | - | [{"date":"2021-12-31","value":70.72,"profit":true},{"date":"2022-12-31","value":79.46,"profit":true},{"date":"2023-12-31","value":98.91,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Income From Discontinued Operations | - | - | - | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Net Income | 966.00M | 1.09B | 1.36B | 1.37B | 1.36B | [{"date":"2021-12-31","value":70.36,"profit":true},{"date":"2022-12-31","value":79.46,"profit":true},{"date":"2023-12-31","value":98.91,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":99.05,"profit":true}] |
| EPS (Diluted) | 9.03 | 10.17 | 10.21 | 9.15 | 10.66 | [{"date":"2021-12-31","value":84.71,"profit":true},{"date":"2022-12-31","value":95.4,"profit":true},{"date":"2023-12-31","value":95.78,"profit":true},{"date":"2024-12-31","value":85.83,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
| IQV | |
|---|---|
| Cash Ratio | 0.26 |
| Current Ratio | 0.75 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| IQV | |
|---|---|
| ROA (LTM) | 5.03% |
| ROE (LTM) | 21.44% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| IQV | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 0.78 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.22 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| IQV | |
|---|---|
| Trailing PE | 21.56 |
| Forward PE | 13.53 |
| P/S (TTM) | 1.76 |
| P/B | 4.62 |
| Price/FCF | 14 |
| EV/R | 2.69 |
| EV/Ebitda | 12.66 |
| PEG | 1.03 |
IQVIA Holdings Inc (IQV) share price today is $166.94
Yes, Indians can buy shares of IQVIA Holdings Inc (IQV) on Vested. To buy
Yes, you can purchase fractional shares of IQVIA Holdings Inc (IQV) via the Vested app. You can start investing in IQVIA Holdings Inc (IQV) with a minimum investment of $1.
You can invest in shares of IQVIA Holdings Inc (IQV) via Vested in three simple steps:
The 52-week high price of IQVIA Holdings Inc (IQV) is $247.05. The 52-week low price of IQVIA Holdings Inc (IQV) is $134.65.
The price-to-earnings (P/E) ratio of IQVIA Holdings Inc (IQV) is 21.5645
The price-to-book (P/B) ratio of IQVIA Holdings Inc (IQV) is 4.62
The dividend yield of IQVIA Holdings Inc (IQV) is 0.00%
The market capitalization of IQVIA Holdings Inc (IQV) is $28.64B
The stock symbol (or ticker) of IQVIA Holdings Inc is IQV
Consider the share price of IQVIA Holdings Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether IQVIA Holdings Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in IQVIA Holdings Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the IQVIA Holdings Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of IQVIA Holdings Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that IQVIA Holdings Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
